Alpha E: no more rejection? [J Exp Med. 2002]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

1: J Exp Med. 2002 Oct 7;196(7):873-5. Links

Alpha E: no more rejection?

The Babraham Institute, Cambridge, CB2 4AT, United Kingdom. peter.kilshaw@bbsrc.ac.uk

PMID: 12370249 [PubMed - indexed for MEDLINE]

PMCID: PMC2194032

Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis.
Le Floc'h A, Jalil A, Vergnon I, Le Maux Chansac B, Lazar V, Bismuth G, Chouaib S, Mami-Chouaib F. J Exp Med. 2007 Mar 19; 204(3):559-70. Epub 2007 Feb 26.

[J Exp Med. 2007]
Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
Zaunders JJ, Ip S, Munier ML, Kaufmann DE, Suzuki K, Brereton C, Sasson SC, Seddiki N, Koelsch K, Landay A, et al. J Virol. 2006 Oct; 80(20):10162-72.

[J Virol. 2006]

Your browsing activity is empty.

Activity recording is turned off.

Display Show